| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/17/2003 | CA2471458A1 Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same |
| 07/17/2003 | CA2471432A1 Nonhuman model animal lacking the ability to control lymphocyte migration |
| 07/17/2003 | CA2471204A1 Inhibitors of dipeptidyl peptidase iv |
| 07/17/2003 | CA2470411A1 System for monitoring bacterial tumor treatment |
| 07/17/2003 | CA2470012A1 Novel proteins and nucleic acids encoding same |
| 07/17/2003 | CA2469177A1 Insulin-responsive dna binding protein-1 and methods to regulate insulin-responsive genes |
| 07/17/2003 | CA2469052A1 Transdifferentiation of pancreatic acinar cells |
| 07/17/2003 | CA2468700A1 Extended glucagon-like peptide-1 analogs |
| 07/17/2003 | CA2463798A1 Modulation of immunostimulatory propertiies of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 07/17/2003 | CA2439471A1 Promoters of the growth and/or differentiation of hematopoietic stem cells and/or hematopoietic progenitors |
| 07/16/2003 | EP1327683A2 Human papilloma virus inhibition by a hairpin ribozyme |
| 07/16/2003 | EP1327681A1 Degraded agonist antibody |
| 07/16/2003 | EP1327639A1 Prediction of cardiovascular disease by genetic polymorphisms in cardiovascular associated genes |
| 07/16/2003 | EP1327628A2 Lipidization of hydrophilic molecules |
| 07/16/2003 | EP1327449A1 Remedies for ischemic diseases |
| 07/16/2003 | EP1327002A2 Antisense modulation of syntaxin 4 interacting protein expression |
| 07/16/2003 | EP1326990A2 Packaging of positive-strand rna virus replicon particles |
| 07/16/2003 | EP1326987A1 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 07/16/2003 | EP1326986A2 Regulation of human sphingosine kinase-like protein |
| 07/16/2003 | EP1326981A2 Pharmaceutical preparations and methods for inhibiting tumors |
| 07/16/2003 | EP1326980A2 Methods of treatment using wisp polypeptides |
| 07/16/2003 | EP1326978A2 Hematopoietin receptors hpr1 and hpr2 |
| 07/16/2003 | EP1326977A2 Human secretin receptor-like gpcr |
| 07/16/2003 | EP1326975A2 Regulation of human secretin receptor-like gpcr |
| 07/16/2003 | EP1326974A2 Methods of using a human il-17-related polypeptide to treat disease |
| 07/16/2003 | EP1326973A2 Regulation of human gpcr-like protein |
| 07/16/2003 | EP1326972A2 Transporters and ion channels |
| 07/16/2003 | EP1326971A2 Proteins and nucleic acids encoding same |
| 07/16/2003 | EP1326969A2 Improved system for regulation of transgene expression |
| 07/16/2003 | EP1326967A2 Novel aggrecanase molecules |
| 07/16/2003 | EP1326893A2 Plasma fraction containing bikunin, method for the production thereof and use of the same |
| 07/16/2003 | EP1326892A2 Compositions that inhibit proliferation of cancer cells |
| 07/16/2003 | EP1326879A2 Nucleic acid constructs and cells, and methods utilizing same for modifying the electrophysiological function of excitable tissues |
| 07/16/2003 | EP1326861A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists |
| 07/16/2003 | EP1326851A1 Substituted dipeptides as growth hormone secretagogues |
| 07/16/2003 | EP1326840A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 07/16/2003 | EP1326825A2 Compounds and compositions for delivering active agents |
| 07/16/2003 | EP1326646A2 Transferrin-polycation/dna complexes for the systemic treatment of tumour diseases using cytotoxic proteins |
| 07/16/2003 | EP1326645A1 Complexes for transferring nucleic acids into cells |
| 07/16/2003 | EP1326644A1 Absorption enhancers |
| 07/16/2003 | EP1326634A1 Vaccine composition comprising an antigen and a peptide having adjuvant properties |
| 07/16/2003 | EP1326632A2 Agents for the treatment of viral infections |
| 07/16/2003 | EP1326631A1 Methods for treating endocrine disorders |
| 07/16/2003 | EP1326630A2 Use of glp-1 and glp-2 peptides |
| 07/16/2003 | EP1326629A2 Methods and compositions for promoting the maturation of monocytes |
| 07/16/2003 | EP1326628A2 Chemokine mutants in the treatment of multiple sclerosis |
| 07/16/2003 | EP1326627A1 Methods of modulating apoptosis by administration of relaxin agonists or antagonists |
| 07/16/2003 | EP1326626A2 Methods for treating rheumatoid arthritis using il-17 antagonists |
| 07/16/2003 | EP1326625A1 Immunogenic composition of hepatitis c and methods of use thereof |
| 07/16/2003 | EP1326604A2 Combination of at least two compounds selected from an at1-receptorantagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups |
| 07/16/2003 | EP1326594A2 Ribavirin-pegylated interferon alfa hcv combination therapy |
| 07/16/2003 | EP1326583A1 Medication delivery devices |
| 07/16/2003 | EP1253933B1 Use of neurotoxins in medicaments for thyroid disorders |
| 07/16/2003 | EP1104675A4 Agent for regulating iodine exchange or for preventing iodine-deficit conditions |
| 07/16/2003 | EP1025231B1 Robo: a family of polypeptides and nucleic acids involved in nerve cell guidance |
| 07/16/2003 | EP1019510B1 Vaccines derived from porcine circoviruses |
| 07/16/2003 | EP0975354A4 Ligand/lytic peptide compositions and methods of use |
| 07/16/2003 | EP0934059B1 Method for preparing malonate methylidene nanoparticles, nanoparticles optionally containing one or several biologically active molecules |
| 07/16/2003 | EP0852586B1 Use of a 24 kDa protein for treating and diagnosing an HCV Infektion |
| 07/16/2003 | EP0830137B1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 07/16/2003 | EP0801658B1 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples |
| 07/16/2003 | EP0789767B1 A method for producing purified papillomavirus proteins |
| 07/16/2003 | EP0760013B1 Treatment of influenza virus infection using antivirals that inhibit acylation/palmitylation of hemagglutinin |
| 07/16/2003 | EP0688365B1 Fertility regulation with transforming growth factor beta |
| 07/16/2003 | CN1430626A Sheep lice Bobicola ovis allergen treatment |
| 07/16/2003 | CN1430519A Combinations of enzyme inhibitor-containing preparations and the use thereof |
| 07/16/2003 | CN1430516A Crystal structures of P-selectin, P-and E-selectin complexes and use thereof |
| 07/16/2003 | CN1430504A Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into biological environmentat from polymer matrix |
| 07/16/2003 | CN1430502A Sustained release pharmaceutical compositions for parenteral administration of hydrophilic compounds |
| 07/16/2003 | CN1430474A Tryptophan source from plants and uses therefor |
| 07/16/2003 | CN1429842A Deer serum active polypeptide crystal preparation and its preparing method |
| 07/16/2003 | CN1429840A New human protein having cancer cell growth in hibiting function and its code sequence |
| 07/16/2003 | CN1429839A New human protein having cancer inhibiting function and its code sequence |
| 07/16/2003 | CN1429836A Hepatitis C virus high change region 1 synthetic peptide and its use |
| 07/16/2003 | CN1429623A Method for treating endothelium wond |
| 07/16/2003 | CN1429559A Anti-adhesion isolator |
| 07/16/2003 | CN1114447C Pharmaceutical antiviral compsn. comprising glycyrrhizic acid and at least one protein endowed with activiral activity |
| 07/15/2003 | US6593461 Isolated DNA of given nucleotide sequence which encodes an amino acid sequence; hybridization; use in diagnosing, preventing and treating gastrointestinal disorders |
| 07/15/2003 | US6593459 Compound for use in the treatment of cancer |
| 07/15/2003 | US6593458 Antibody for use in the treatment of cancer |
| 07/15/2003 | US6593457 Lymphocyte-derived antimicrobial protein (LDAP) and methods of isolating and producing and using the protein |
| 07/15/2003 | US6593456 Polypeptide for use in the treatment rheumatoid arthritis |
| 07/15/2003 | US6593455 Tripeptide amides that block viral infectivity and methods of use thereof |
| 07/15/2003 | US6593453 Activated peptides and conjugates |
| 07/15/2003 | US6593310 Add to a mammal in need of such treatment an effective amount, typically in the range of 0.1 to 100 micrograms per kg of body weight, of a compound capable of maintaining the integrity of connective tissue, for example pentosan polysulfate. |
| 07/15/2003 | US6593305 Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase |
| 07/15/2003 | US6593304 Recombinant dna comprising dna coding for myosin heavy chain sm1 iso-form protein inserted into vector dna microorganism carrying the recombinant dna, and an agent for treatment of arteriosclerosis comprising the recombinant dna |
| 07/15/2003 | US6593300 Inhibitors of the interleukin-1 beta converting enzyme |
| 07/15/2003 | US6593297 Compounds and methods for inhibiting cancer metastasis |
| 07/15/2003 | US6593296 Stabilized growth hormone formulation and method of preparation thereof |
| 07/15/2003 | US6593295 Long lasting insulinotropic peptides |
| 07/15/2003 | US6593294 Coagulation factor VIII and substantially neutral colloidal particles comprising 1-20 mole percent of an amphipathic lipid derivatized with a biocompatible hydrophilic polymer for treatment of hemophilia |
| 07/15/2003 | US6593292 Amidine and/or guanidine substituted peptoid and drug conjugates for drug delivery across endo/epithelial tissue |
| 07/15/2003 | US6593291 Inhibition of endothelial cell proliferation inhibits neovascularization |
| 07/15/2003 | US6593290 Treatment of inner ear hair cells |
| 07/15/2003 | US6593133 Neurotrophic factors |
| 07/15/2003 | US6593132 Nucleotide sequences coding polypeptide for use in the treatment of cancer |
| 07/15/2003 | US6593125 Human kinases and polynucleotides encoding the same |
| 07/15/2003 | US6593124 Hybrid genes for expression of stimulatory factors in activated T cells |
| 07/15/2003 | US6593121 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of nervous system disorders |